Overview

Efficacy of Ramelteon in Adults With Chronic Insomnia

Status:
Terminated
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate subjectively reported treatment effects of ramelteon, once daily (QD), in adults with chronic insomnia.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda